Advertisement

Emergence of MRSA in the Community

  • Lacey P. Gleason
  • David C. Ham
  • Valerie Albrecht
  • Isaac See
Chapter
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)

Abstract

Antimicrobial-resistant variants of S. aureus have been known to cause human disease for decades, primarily in healthcare settings. However, methicillin-resistant S. aureus (MRSA) infections emerged in the community in the United States during the late 1990s–early 2000s. Community-associated MRSA (CA-MRSA) infections are often caused by unique strain types that produce characteristic clinical manifestations. Although new antimicrobials are available, it is unclear how they should be used in the treatment of CA-MRSA. Preventing MRSA infections in the community requires engagement of public health officials, clinical providers, patients, and community members. The epidemiology of community-associated MRSA continues to evolve, and continued monitoring of MRSA to assess for new developments and novel strategies for prevention will be critical in the upcoming years.

Notes

Acknowledgments/Disclaimer

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention, the Public Health Service, or the US Department of Health and Human Services. The authors would like to thank the authors of the previous version of this chapter (Adam Cohen, Daniel Jernigan, and Rachel Gorwitz) for permission to include some materials from the previous edition.

References

  1. 1.
    Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TY. Methicillin-resistant Staphylococcus aureus in two child care centers. J lnfect Dis. 1998;178:577–80.CrossRefGoogle Scholar
  2. 2.
    Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, Boyle-Vavra S, Daum RS. Staphylococcus aureus Sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353:1245–51.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Alam MT, Read TD, Petit RA, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ. Transmission and microevolution of USA300 MRSA in US households: evidence from whole genome sequencing. MBio. 2015;6:e00054-15.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Albrecht VS, Limbago BM, Moran GJ, Krishnadasan A, Gorwitz RJ, McDougal LK, Talan DA, The EMERGency ID NET Study Group. Staphylococcus aureus colonization and strain type at various body sites among patients with a closed abscess and uninfected controls at US emergency departments. J Clin Microbiol. 2015;53:3478–84.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A, Martinez P, Butler JC. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. lnfect Control Hosp Epidemiol. 2003;24:397–402.CrossRefGoogle Scholar
  6. 6.
    Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, Sparks R, Donlan RM, Martinez P, Mongkolrattanothai K, Butler JC. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis. 2004;189:1565–73.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Barber M, Rozwadowska-Dowzenko M. Infection by penicillin-resistant staphylococci. Lancet. 1948;1:641–4.CrossRefGoogle Scholar
  8. 8.
    Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 1968;279:441–8.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Begier EM, Frenette K, Barrett NL, Mshar P, Petit S, Boxrud DJ, Watkins-Colwell K, Wheeler S, Cebelinski EA, Glennen A, Nguyen D, Hadler JL, Connecticut Bioterrorism Field Epidemiology Response Team. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis. 2004;39:1446–53.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, Eiden J, Gruber WC, Jansen KU, Anderson AS, Gurtman A. SA4g, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine. 2017;35:1132–9.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL, Klimov A, Lindstrom SE, Balish A, Medina MJ, Wallis TR, Guarner J, Paddock CD, Shieh WJ, Zaki SR, Sejvar JJ, Shay DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM, Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559–67.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Calfee DP, Salgado CD, Milstone AM, Harris AD, Kuhar DT, Moody J, Aureden K, Huang SS, Maragakis LL, Yodoe DS, Society for Healthcare Epidemiology of America. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35:s108–32.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP, Minarcik JR, Crum NF, Ryan MA. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol. 2004;42:4050–43.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Cardona AF, Wilson SE. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment. Clin Infect Dis. 2015;61:S69–78.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Casey JA, Curriero FC, Cosgrove SE, Nachman KE, Schwartz BS. High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania. JAMA Int Med. 2013;173:1980.CrossRefGoogle Scholar
  16. 16.
    Cefai C, Ashurst S, Owens C. Human carriage of methicillin-resistant Staphylococcus aureus linked with pet dog. Lancet. 1994;344:539–40.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep. 1999;48:707–10.Google Scholar
  18. 18.
    Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:919–22.Google Scholar
  19. 19.
    Centers for Disease Control and Prevention. Staphylococcus aureus Resistant to vancomycin—United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:565–7.Google Scholar
  20. 20.
    Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus—Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:902.Google Scholar
  21. 21.
    Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:793.Google Scholar
  22. 22.
    Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep. 2003;52:992–6.Google Scholar
  23. 23.
    Centers for Disease Control and Prevention. Infectious disease and dermatologic conditions in evacuees and rescue workers after hurricane Katrina—multiple states, august-September, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:961–4.Google Scholar
  24. 24.
    Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients—Ohio, Kentucky, and Vermont, 2004-2005. MMWR Morb Mortal Wkly Rep. 2006;55:677–9.Google Scholar
  25. 25.
    Centers for Disease Control and Prevention. Severe co-infection with seasonal influenza a (H3N2) virus and Staphylococcus aureus – Maryland, February-march 2012. MMWR Morb Mortal Wkly Rep. 2012;61:289–91.Google Scholar
  26. 26.
    Centers for Disease Control and Prevention. Emerging infections program network report: methicillin-resistant Staphylococcus aureus, 2015. Published February 28, 2017. Available online at: https://www.cdc.gov/hai/eip/pdf/2015-MRSA-Report.pdf. 2017.
  27. 27.
    Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178–82.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Wayne: The Institute; 2006. p. M100–S16.Google Scholar
  29. 29.
    Cohen AL, Shuler C, McAllister S, Fosheim GE, Brown MG, Abercrombie D, Anderson K, McDougal LK, Drenzek C, Arnold K, Jernigan D, Gorwitz R. Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections. Emerg Infect Dis. 2007;13:1707–13.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol. 2007;8:259–70.PubMedCrossRefGoogle Scholar
  31. 31.
    Coronado F, Nicholas JA, Wallace BJ, Kohlerschmidt DJ, Musser K, SchoonmakerBopp DJ, Zimmerman SM, Boller AR, Jernigan DB, Kacica MA. Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community. Epidemiol Infect. 2006;135:492–501.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Crisp JG, Takhar SS, Moran GJ, Krishnadasan A, Dowd SE, Finegold SM, Summanen PH, Talan DA, EMERGency ID Net Study Group. Inability of polymerase chain reaction, pyrosequencing, and culture of infected and uninfected site skin biopsy specimens to identify the cause of cellulitis. Clin Infect Dis. 2015;61:1679–87.PubMedGoogle Scholar
  33. 33.
    David MZ, Rudolph KM, Hennessey TW, Boyle-Vavra B, Daum RS. Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerg Infect Dis. 2008;14:1693–9.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    David MZ, Cadilla A, Boyle-Vavra S, Daum RS. Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the Midwestern United States, 2004-2005 to 2008. PLoS One. 2014;9:e92760.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Porsa E, Schumm LP, Boyle-Vavra S, Daum RS. A randomized, controlled trial of Chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail. Infect Control Hosp Epidemiol. 2014;35:1466–73.PubMedCrossRefGoogle Scholar
  36. 36.
    Davis J, Jackson C, Fedorka-Cray P, Barrett J, Brousse J, Gustafson J, Kucher M. Carriage of methicillin-resistant staphylococci by healthy companion animals in the US. Lett Appl Microbiol. 2014;59:1–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Dekker JP, Frank KM. Next-generation epidemiology: using real-time core genome multilocus sequence typing to support infection control policy. J Clin Microbiol. 2016;54:2850–3.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557–68.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Dhand A, Sakoulas G. Daptomycin in combination with other antibiotics in the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia. Clin Ther. 2014;36:1303–16.PubMedCrossRefGoogle Scholar
  40. 40.
    Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, JS MD, Doern GV. Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide study. Infect Control Hosp Epidemiol. 2014;35:285–92.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006;367:731–9.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Dominguez TJ. It’s not a spider bite, it’s community-acquired methicillin-resistant Staphylococcus aureus. Am Board Fam Med. 2004;17:220–6.CrossRefGoogle Scholar
  43. 43.
    Duijekeren EV, Wolfhagen MJ, Box AT, Heck ME, Wannet WJ, Fluit AC. Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2004;10:2235–7.CrossRefGoogle Scholar
  44. 44.
    Duijekeren E, Wolfhagen MJ, Heck ME, Wannet WJ. Transmission of a panton-valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J Clin Microbiol. 2005;43:6209–11.CrossRefGoogle Scholar
  45. 45.
    Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the Management of Community-Acquired Skin Abscesses in the pediatric patient. Ann Emerg Med. 2010;55:401–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Ekkelenkamp MB, Sekkat M, Carpaij N, Troelstra A, Bonten MJ. Endocarditis due to methicillin-resistant Staphylococcus aureus originating from pigs. Ned Tijdschr Geneeskd. 2006;150:2442–7.PubMedGoogle Scholar
  47. 47.
    Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Estivariz CF, Park SY, Hageman JC, Dvorin J, Melish MM, Arpon R, Coon P, Slavish S, Kim M, McDougal LK, Jensen B, McAllister S, Lonsway D, Killgore G, Effler PE, Jernigan DB. Emergence of community-associated methicillin-resistant Staphylococcus aureus in Hawaii, 2001-2003. J Infect. 2007;54:349–57.PubMedCrossRefGoogle Scholar
  49. 49.
    Faires MC, Tater KC, Weese JS. An investigation of methicillin-resistant Staphylococcus aureus colonization in people and pets in the same household with an infected person or infected pet. J Am Vet Med Assoc. 2009;235:540–3.PubMedCrossRefGoogle Scholar
  50. 50.
    Fekety FR, Bennett IL Jr. The epidemiological virulence of staphylococci. Yale J Biol Med. 1959;32:23–32.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Ferreira JP, Anderson KL, Correa MT, Lyman R, Ruffin F, Reller LB, Fowler VG. Transmission of MRSA between companion animals and infected human patients presenting to outpatient medical care facilities. PLoS One. 2011;6:e26978.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41:4740–4.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Fleisch F, Zbinden R, Vanoli C, Ruef C. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis. 2001;32:581–6.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Frank AL, Marcinak JF, Mangat PD, Tjhio JT, Kelkar S, Schreckenberger PC, Quinn JP. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2002;21:530–4.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Freitas EAF, Harris RM, Blake RK, Salgado CD. Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance. Infect Control Hosp Epidemiol. 2010;31:469–75.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436–44.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Fritz SA, Hogan PG, Hayek G, Eisenstein KA, Rodriguez M, Epplin EK, Garbutt J, Fraser VJ. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis. 2011;54:743–51.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Fritz SA, Hogan PG, Singh LN, Thompson RM, Wallace MA, Whitney K, Al-Zubeidi D, Burnham CD, Fraser VJ. Contamination of environmental services with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus. JAMA Ped. 2014;168:1030–8.CrossRefGoogle Scholar
  59. 59.
    Giersing BK, Dastgheyb SS, Modjarrad K, Moorthy V. Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine. 2016;34:2962–6.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Gingrich EN, Kurt T, Hyatt DR, Lappin MR, Ruch-Gallie R. Prevalence of methicillin-resistant staphylococci in northern Colorado shelter animals. J Vet Diagn Investig. 2011;23:947–50.CrossRefGoogle Scholar
  61. 61.
    Glaser P, Martins-Simoes P, Villain A, Barbier M, Tristan A, Bouchier C, Ma L, Bes M, Laurent F, Guillemot D, Wirth T, Vandenesch F. Demography and Intercontinental spread of the USA300 community acquired methicillin-resistant Staphylococcus aureus lineage. mBio. 2016;7:e02183–15.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197:1226–34.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Groom AV, Wolsey DH, NaimI TS, Smith K, Johnson S, Boxrud D, Moore KA, Cheek JE. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286:1201–5.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Grumann D, Nübel U, Bröker BM. Staphylococcus aureus Toxins--their functions and genetics. Infect Genet Evol. 2014;21:583–92.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Gualandi NR, Mu Y, Dumyati G, Harrison L, Lesher L, Nadle L, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S, See I. Racial disparities in invasive methicillin-resistant Staphylococcus aureus infections, 2005–2012. 2015 Council of State and Territorial Epidemiologists Annual Conference, Boston, MA. Presented June 15, 2015. Abstract #4203; 2015.Google Scholar
  66. 66.
    Hageman JC, UyekI TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinivasan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, McDonald C. Severe community-acquired pneumonia caused by an emerging strain of Staphylococcus aureus during the 2003-04 influenza season. Emerg Infect Dis. 2006;12:894–9.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Ham DC, Jackson K, Bamberg W, Dumyati G, Harrison L, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Kallen AJ, See I. Community associated invasive methicillin-resistant Staphylococcus aureus (MRSA), 2005–2014. Spring 2017 Conference for the Society for Healthcare Epidemiology of America, St Louis, MO. Presented March 31, 2017. Abstract #8707; 2017.Google Scholar
  68. 68.
    Hatcher SM, Rhodes SM, Stewart JR, Silbergeld E, Pisanic N, Larsen J, Jiang S, Krosche A, Hall D, Carroll KC, Heaney CD. The prevalence of antibiotic-resistant Staphylococcus aureus nasal carriage among industrial hog operation workers, community residents, and children living in their households: North Carolina, USA. Environ Health Perspect. 2017;125:560–9.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Heller J, Innocent G, Denwood M, Reid S, Kelly L, Mellor D. Assessing the probability of acquisition of meticillin-resistant Staphylococcus aureus (MRSA) in a dog using a nested stochastic simulation model and logistic regression sensitivity analysis. Prev Vet Med. 2011;99:211–24.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Heller J, Kelly L, Reid SW, Mellor DJ. Qualitative risk assessment of the acquisition of Meticillin-resistant Staphylococcus aureus in pet dogs. Risk Anal. 2010;30:458–72.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Herold BC, lmmergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, BoyleVavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593–8.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, Murdoch D, Pottumarthy S, Roberts SA, Swager C, Taylor SL, Thomas MG, Wong CG, Morris AJ. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97–103.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillinresistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997;40:135–6.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Int Med. 2007;167:1026–33.CrossRefGoogle Scholar
  75. 75.
    Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Bombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JJ, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perline JB, Platt R. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368:2255–65.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Humphreys H, Fitzpatrick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why? Clin Infect Dis. 2015;61:1708–14.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Hwang JH, Tsai HY, Liu TC. Community-acquired methicillin-resistant Staphylococcus aureus infections in discharging ears. Acta Otolaryngol. 2002;122:827–30.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC. Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics. 2013;132:e817.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Jessen O, Rosendal K, Bulow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med. 1969;281:627–35.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Jevons MP. “Celbenin”-resistance staphylococci. BMJ. 1961;1:124.CrossRefGoogle Scholar
  81. 81.
    Kallen AJ, Driscoll TJ, Thornton S, Olson PE, Wallace MR. Increase in community-acquired methicillin-resistant Staphylococcus aureus at a Naval Medical Center. Infec Control Hosp Epidemiol. 2000;21:223–6.CrossRefGoogle Scholar
  82. 82.
    Kaplan SL. Implications of methicillin-resistant Staphylococcus aureus as a communityacquired pathogen in pediatric patients. lnfect Dis Clin North Am. 2005;19:747–57.CrossRefGoogle Scholar
  83. 83.
    Kaplan SL, Forbes A, Hammerman WA, Lamberth L, Hulten KG, Minard CG, Mason EO. Randomized trial of “bleach baths” plus routine hygienic measures vs routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis. 2013;58:679–82.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin-resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44:1549–55.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal LK, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352:468–75.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Kazmierczak Z, Gorski A, Dabrowska K. Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Virus. 2014;6:2551–70.CrossRefGoogle Scholar
  87. 87.
    Kirby WMM. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science. 1944;99:452–3.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–71.CrossRefPubMedGoogle Scholar
  89. 89.
    Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M, Enright MC, Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR, Schulz-Trieglaff OB, Smith GP, Peacock SJ. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med. 2012;366:2267–75.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin lnfect Dis. 2003;37:933–8.CrossRefGoogle Scholar
  91. 91.
    Lee NE, Taylor MM, Bancroft E, Ruane PJ, Morgan M, McCoy L, Simon PA. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis. 2005;40:1529–34.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, AS DV, Schaffner W, Nadle J, Gershman K, Fridkin SK, Active Bacterial Core surveillance (ABCs); MRSA Investigators of the Emerging Infections Program. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line associated bloodstream infections. Clin Infect Dis. 2012;55:232–41.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med. 1982;97:330–8.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK, Active Bacterial Core Surveillance MRSA Investigators. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol. 2009;47:1344–51.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Limbago BM, Kallen AJ, Zhu W, Eggers P, McDougal LK, Albrecht VS. Report of the 13th vancomycin-resistant Staphylococcus aureus isolates from the United States. J Clin Microbiol. 2014;52:998–1002.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin lnfect Dis. 1999;29:1128–32.CrossRefGoogle Scholar
  97. 97.
    Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18–55.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev. 2003;(4):CD003340.Google Scholar
  99. 99.
    Mammina C, Calà C, Plano MR, Bonura C, Vella A, Monastero R, Palma DM. Ventilator-associated pneumonia and MRSA ST398, Italy. Emerg Infect Dis. 2010;16:730–1.PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Mancini F, Monaci E, Lofano G, Torre A, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Galletti B, Laera D, Pallaoro M, Tuscano G, Fontana MR, Bensi G, Grandi G, Rossi-Paccani S, Nuti S, Rappuoli R, De Gregorio E, Bagnoli F, Soldaini E, Bertholet S. One dose of Staphylococcus aureus 4C-staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T cells, and IL-17A. PLoS One. 2016;11:e0147767.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Manian FA. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis. 2003;36:e26–8.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr lnfect Dis J. 2004;23:701–6.CrossRefGoogle Scholar
  103. 103.
    McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113–20.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B. Necrotizing fasciitis caused by communityassociated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–53.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS. Staphylococcus aureus Colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis. 2012;54:1523–35.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Miller MB, Weber DJ, Goodrich JS, Popowitch EB, Poe MD, Nguyen V, Shope TR, Foster DT, Miller JR, Kotch J. Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers. J Clin Microbiol. 2011;49:1041–7.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005;11:928–30.PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Albrecht V, Limbago B, Talan DA, EMERGEncy ID NET Study Group. Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis. 2012;54(8):1126–33.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Moran GJ, Krishnadasan A, Mower WR, Abrahamian FM, LoVecchio F, Steele MT, Rothman RE, Karras DJ, Hoagland R, Pettibone S, Talan DA. Effect of cephalexin plus trimethoprim-sulfamethoxazole vs. cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial. JAMA. 2017;317:2088–96.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Morgan DJ, Murthy R, Munoz-Price LS, Barnden M, Camins BC, Johnston BL, Rubin Z, Sullivan KV, Shane AL, Dellinger EP, Rupp ME, Bearman G. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2015;36:1163–72.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Morris DO, Lautenbach E, Zaoutis T, Leckerman K, Edelstein PH, Rankin SC. Potential for pet animals to harbour methicillin-resistant Staphylococcus aureus when residing with human MRSA patients. Zoonoses Public Health. 2012;59:286–93.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Naimi TS, Ledell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Besser JM, O'Boyle C, Danila RN, Cheek JE, Osterholm MT, Moore KA, Smith KE. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990–6.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Nair R, Ammann E, Rysavy M, Schweizer ML. Mortality among patients with methicillin-resistant Staphylococcus aureus USA300 versus non-USA300 invasive infections: a meta-analysis. Infect Control Hosp Epidemiol. 2014;35:31–41.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Nerby JM, Gorwitz R, Lesher L, Juni B, Jawahir S, Lynfield R, Harriman K. Risk factors for household transmission of community associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2011;30:927–32.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Neyra RC, Frisancho JA, Rinsky JL, Resnick C, Carroll KC, Rule AM, Ross T, You Y, Price LB, Silbergeld EK. Multidrug-resistant and methicillin-resistant Staphylococcus aureus (MRSA) in hog slaughter and processing plant workers and their community in North Carolina (USA). Environ Health Perspect. 2014;122:471–7.PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Ng W, Faheem A, McGeer A, Simor AE, Gelosia A, Willey BM, Watt C, Richardson DC, Wong H, Ostrowska K, Vernich L, Muller MP, Gnanasuntharam P, Porter V, Katz K. Community and healthcare associated methicillin-resistant Staphylococcus aureus strains: an investigation into household transmission, risk factors, and environmental contamination. Infect Control Hosp Epidemiol. 2017;38:61–7.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11:526–32.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Nimmo GR. USA300 abroad: global spread of a virulent strain of community associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2012;18:725–34.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Ogston A. Micrococcus poisoning. J Anat. 1882;17:24–58.Google Scholar
  120. 120.
    O’Hara FP, Suaya JA, Ray GT, Baxter R, Brown ML, Mera RM, Close NM, Thomas E, Amrine-Madsen H. Spa typing and multilocus sequence typing show comparable performance in a macroepidemiologic study of Staphylococcus aureus in the United States. Microb Drug Resist. 2016;22:88–96.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Panton PN, Valentine FC. Staphylococcal toxin. Lancet. 1932;222:506–8.CrossRefGoogle Scholar
  122. 122.
    Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871–7.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Planet PJ, LaRussa SJ, Dana A, Smith H, Xu A, Ryan C, Uhlemann AC, Boundy S, Goldberg J, Narechania A, Kulkarni R, Ratner AJ, Geoghegan JA, Kolokotronis SO, Prince A. Emergence of the epidemic of methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skin. mBio. 2013;4:e00889–13.PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Planet PJ, Diaz L, Kolokotronis S, Narechania A, Reyes J, Xing G, Rincon S, Smith H, Panesso D, Ryan C, Smith DP, Guzman M, Zurita J, Sebra R, Deikus G, Nolan RL, Tenover FC, Weinstock GM, Robinson DA, Arias CA. Parallel epidemics of community associated methicillin-resistant Staphylococcus aureus USA300 infection in North and South America. J Infect Dis. 2015;212:1874–82.PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Podewils LJ, Liedtke LA, McDonald LC, Hageman JC, Strausbaugh LJ, Fischer TK, Jernigan DB, Uyeki TM, Kuehnert MJ. A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis. 2005;40:1693–6.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Popovich KJ, Hota B, Aroutcheva A, Kurien L, Patel J, Lyles-Banks R, Grasso AE, Spec A, Beavis KG, Hayden MK, Weinstein RA. Community associated methicillin-resistant Staphylococcus aureus colonization burden and HIV-infected patients. Clin Infect Dis. 2013;56:1067–74.PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Popovich KJ, Snitkin ES, Hota B, Green SJ, Pirani A, Aroutcheva A, Weinstein RA. Genomic and epidemiological evidence for community origins of hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infections. J Infect Dis. 2017;215:1640–7.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Raczniak GA, Gaines J, Bulkow LR, Kinzer MH, Hennessy TW, Klejka JA, Bruce MG. A survey of knowledge, attitudes, and practices towards skin and soft-tissue infections in rural Alaska. Int J Circumpolar Health. 2016;75:30603.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a US population: a retrospective population-based study. BMC Infect Dis. 2013;13:252.PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Rhee Y, Aroutcheva A, Hota B, Weinstein RA, Popovich KJ. Evolving epidemiology of Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2015;36:1417–22.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Rolo J, Miragaia M, Turlej-Rogacka A, Empel J, Bouchami O, Faria NA, Tavares A, Hryniewicz W, Fluit AC, de Lencastre H, The CONCORD Working Group. High genetic diversity among community associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One. 2012;7:e34768.PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Ross S, Rodriguez W, Controni G, Khan W. Staphylococcal susceptibility to penicillin G. The changing pattern among community strains. JAMA. 1974;229:1075–7.PubMedCrossRefPubMedCentralGoogle Scholar
  133. 133.
    Rossi F, Diaz L, Wollam A, Panesso D, Zhou Y, Rincon S, Narechania A, Xing G, Di Gioia TS, Doi A, Tran TT, Reyes J, Munita JM, Carvajal LP, Hernandez-Roldan A, Brandão D, van der Heijden IM, Murray BE, Planet PJ, Weinstock GM, Arias CA. Transferable vancomycin resistance in a community associated MRSA lineage. N Engl J Med. 2014;370:1524–31.PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Santos F, Mankarious LA, Eavey RD. Methicillin-resistant Staphylococcus aureus: pediatric otitis. Arch Otolaryngol Head Neck Surg. 2000;126:1383–5.PubMedCrossRefPubMedCentralGoogle Scholar
  135. 135.
    Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann lntern Med. 1982;96:11–6.CrossRefGoogle Scholar
  136. 136.
    Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr lnfect Dis J. 2002;21:910–7.CrossRefGoogle Scholar
  137. 137.
    Schinasi L, Wing S, Augustino KL, Ramsey KM, Nobles DL, Richardson DB, Price LB, Aziz M, PD MD, Stewart JR. A case control study of environmental and occupational exposures associated with methicillin resistant Staphylococcus aureus nasal carriage in patients admitted to a rural tertiary care hospital in a high density swine region. Environ Health. 2014;13:54.PubMedPubMedCentralCrossRefGoogle Scholar
  138. 138.
    Schmidt CS, White CJ, Ibrahim AS, Filler SG, Yeaman MR, Edwards JE Jr, Hennessey JP Jr. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine. 2012;30:7594–600.PubMedPubMedCentralCrossRefGoogle Scholar
  139. 139.
    Schmitz GR, Bruner D, Pitotti R, Olderog C, Livengood T, Williams J, Huebner K, Lightfoot J, Ritz B, Bates C, Schmitz M, Mete M, Deye G. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 2010;56:283–7.PubMedCrossRefPubMedCentralGoogle Scholar
  140. 140.
    See I, Albrecht V, Mu Y, Dumyati G, Koeck M, Lynfield R, Nadle J, Ray SM, Schaffner W, Limbago B, Kallen A. Changes in incidence and strains of methicillin-resistant Staphylococcus aureus bloodstream infections, 2005–2013. IDweek 2016 conference, New Orleans, LA. Presented October 29, 2016. Abstract #1750; 2016.Google Scholar
  141. 141.
    See I, Wesson P, Gualandi N, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Reisenauer C, Schaffner W, Tunali A, Mu Y, Ahern J. Socioeconomic factors explain racial disparities in invasive community-associated methicillin-resistant Staphylococcus aureus disease rates. Clin Infect Dis. 2017;64:597–604.PubMedPubMedCentralCrossRefGoogle Scholar
  142. 142.
    Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the healthcare infection control practices advisory committee (HICPAC). MMWR Recomm Rep. 2003;52:1–42.PubMedPubMedCentralGoogle Scholar
  143. 143.
    Self WH, Wunderink RG, Williams DJ, Zhu Y, Anderson EJ, Balk RA, Fakhran SS, Chappell JD, Casimir G, Courtney DM, Trabue C, Waterer GW, Bramley A, Magill S, Jain S, Edwards KM, Grijalva CG. Staphylococcus aureus Community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis. 2016;63(3):300–9.PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infec Dis. 2013;13:43–54.CrossRefGoogle Scholar
  145. 145.
    Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003;37:1257–60.PubMedCrossRefPubMedCentralGoogle Scholar
  146. 146.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at: https://www.cdc.gov/infectioncontrol/guidelines/mdro/. 2006.
  147. 147.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Available at http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Isolation2007.pdf. 2007.
  148. 148.
    Singer AJ, Talan DA. Management of Skin Abscesses in the era of methicillin-resistant Staphylococcus aureus. N Engl J Med. 2014;370:1039–47.PubMedCrossRefPubMedCentralGoogle Scholar
  149. 149.
    Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med. 1998;32:153–4.PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–406.PubMedCrossRefPubMedCentralGoogle Scholar
  151. 151.
    Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, Moran GJ, EMERGEncy ID Net Study Group. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis. 2011;15:144–9.CrossRefGoogle Scholar
  152. 152.
    Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, Steele MT, Rothman RE, Hoagland R, Moran GJ. Trimethoprim–Sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–32.PubMedPubMedCentralCrossRefGoogle Scholar
  153. 153.
    Toleman MS, Reuter S, Coll F, Harrison EM, Blane B, Brown NM, Török ME, Parkhill J, Peacock SJ. Systematic surveillance detects multiple silent introductions and household transmission of methicillin-resistant Staphylococcus aureus USA300 in the east of England. J Infect Dis. 2016;214:447–53.PubMedPubMedCentralCrossRefGoogle Scholar
  154. 154.
    Tong SYC, Nelson J, Paterson DL, Fowler VG, Howden BP, Cheng AC, Chatfield M, Lipman J, Van Hal S, O’Sullivan M, Robinson JO, Yahav D, Lye D, Davis JS, CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Network. CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomized controlled trial. Trials. 2016;17:170.PubMedPubMedCentralCrossRefGoogle Scholar
  155. 155.
    Uhlemann AC, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MTG, Peacock SJ, Lowy FD. Molecular tracing of the emergence, diversification, and the transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci. 2014;111:6739–43.CrossRefGoogle Scholar
  156. 156.
    Uhlemann AC, Otto M, Lowy FD, DeLeo FR. Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect Genet Evol. 2014;21:563–74.PubMedCrossRefGoogle Scholar
  157. 157.
    van Cleef BA, Verkade EJ, Wulf MW, Buiting AG, Voss A, Huijsdens XW, van Pelt W, Mulders MN, Kluytmans JA. Prevalence of livestock-associated MRSA in communities with high pig-densities in the Netherlands. PLoS One. 2010;5:e9385.PubMedPubMedCentralCrossRefGoogle Scholar
  158. 158.
    VandenBergh MF, Yzerman EP, Van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol. 1999;37:3133–40.PubMedPubMedCentralGoogle Scholar
  159. 159.
    Vayalumkal JV, Suh KN, Toye B, Ramotar K, Saginur R, Roth VR. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA): an affliction of the underclass. CJEM. 2012;14:335–43.PubMedGoogle Scholar
  160. 160.
    Vetter RS, Bush SP. Reports of presumptive brown recluse spider bites reinforce improbable diagnosis in regions of North America where the spider is not endemic. Clin Infect Dis. 2002;35:442–5.PubMedCrossRefGoogle Scholar
  161. 161.
    von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344:11–6.CrossRefGoogle Scholar
  162. 162.
    Walters M, Eggers P, Albrecht V, Travis T, Lonsway D, Hovan G, Taylor D, Rasheed K, Limbago B, Kallen A. Notes from the field: Vancomycin-resistant Staphylococcus aureus — Delaware, 2015. MMWR. 2015;64:1056.PubMedPubMedCentralGoogle Scholar
  163. 163.
    Wang J, Barth S, Richardson M, Corson K, Mader J. An outbreak of methicillin resistant Staphylococcus aureus cutaneous infection in a saturation diving facility. Undersea Hyperb Med. 2003;30:277–84.PubMedPubMedCentralGoogle Scholar
  164. 164.
    Wardyn SE, Forshey BM, Farina SA, Kates AE, Nair R, Quick MK, Wu JY, Hanson BM, O’Malley SM, Shows HW, Heywood EM, Beane-Freeman LE, Lynch CF, Carrel M, Smith TC. Swine farming is a risk factor for infection with and high prevalence of carriage of multidrug-resistant Staphylococcus aureus. Clin Infect Dis. 2015;61:59–66.PubMedPubMedCentralCrossRefGoogle Scholar
  165. 165.
    Weese JS, Archambault M, Willey BM, Hearn P, Kreiswirth BN, Said-Salim B, McGeer A, Likhoshvay Y, Prescott JF, Low DE. Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis. 2005;11:430–5.PubMedPubMedCentralCrossRefGoogle Scholar
  166. 166.
    Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003;302:1569–71.PubMedCrossRefGoogle Scholar
  167. 167.
    Wejnert C, Hess KL, Hall HI, Van Handel MV, Hayes D, Fulton P, An Q, Koenig LJ, Prejean J, Valleroy LA. Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs — United States. MMWR Morb Mortal Wkly Rep. 2016;65:1336–42.PubMedCrossRefPubMedCentralGoogle Scholar
  168. 168.
    Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev. 1963;27:56–71.PubMedPubMedCentralGoogle Scholar
  169. 169.
    Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, MankanI M, Mackersie R, Schecter WP. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004;139:947–51.PubMedCrossRefGoogle Scholar
  170. 170.
    Zinderman CE, Conner B, Malakooti MA, Lamar JE, Armstrong A, Bohnker BK. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis. 2004;10:941–4.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Lacey P. Gleason
    • 1
  • David C. Ham
    • 1
  • Valerie Albrecht
    • 1
  • Isaac See
    • 1
  1. 1.Division of Healthcare Quality PromotionCenters for Disease Control and PreventionAtlantaUSA

Personalised recommendations